We are live on
!
Find out more
Chevy Chase Trust Portfolio holdings
AUM
$34.7B
1-Year Est. Return
29.45%
This Fund
S&P 500
This Quarter
Est. Return
+0.88%
1 Year Est. Return
+29.45%
3 Year Est. Return
+102.04%
5 Year Est. Return
+142.29%
10 Year Est. Return
+523.99%
AUM
$28.7B
AUM Growth
-$699M
(-2.4%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-2.64%
Top 10 Holdings %
Top 10 Hldgs %
27.85%
Holding
686
New
11
Increased
74
Reduced
531
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$79.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$26.1M |
| 3 |
Match Group
MTCH
|
+$25.9M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$25M |
| 5 |
Analog Devices
ADI
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$54.1M |
| 2 |
Apple
AAPL
|
+$53.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$26.5M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$25.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Financials | 13.83% |
| 3 | Healthcare | 13.75% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
SPX Corp
SPXC
$9.98B
| – | – |
-4,159
| Closed | -$254K |
|
677
Simpson Manufacturing
SSD
$7.68B
| – | – |
-2,353
| Closed | -$260K |
|
678
Unum
UNM
$13.7B
| – | – |
-130,145
| Closed | -$3.7M |
|
679
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
| – | – |
-845
| Closed | -$245K |
|
680
Vanguard Industrials ETF
VIS
$8.04B
| – | – |
-1,613
| Closed | -$317K |
|
|
VRE
681
DELISTED
Veris Residential
VRE
| – | – |
-10,000
| Closed | -$172K |
|
682
Wayfair
W
$11.9B
| – | – |
-723
| Closed | -$228K |
|
683
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| – | – |
-1,500
| Closed | -$203K |
|
|
TLMD
684
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
| – | – |
-26,400
| Closed | -$150K |
|
|
MXIM
685
DELISTED
Maxim Integrated Products
MXIM
| – | – |
-171,005
| Closed | -$18M |
|
|
ALXN
686
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-140,836
| Closed | -$25.9M |
|
Similar funds
VIA
SAM
Chevy Chase Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Chevy Chase Trust held 686 positions worth $28.7B, down 2.4% from $29.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Chevy Chase Trust's Q3 2021 filing shows 11 new, 74 increased, 531 reduced and 25 closed positions. Its largest new stake was Moderna: 216,506 shares worth $83.3M. The largest sale was Microsoft, an estimated $54.1M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Chevy Chase Trust's largest Q3 2021 buy was Moderna: 216,506 shares worth $83.3M.
- Chevy Chase Trust added most to iShares Core S&P 500 ETF in Q3 2021, an estimated $26.1M increase.
- Chevy Chase Trust's biggest Q3 2021 reduction was Microsoft, cutting an estimated $54.1M.
- Chevy Chase Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $25.9M.
- Chevy Chase Trust's ten largest holdings make up 28% of its $28.7B portfolio in Q3 2021.
- Chevy Chase Trust opened 11 new positions and closed 25 in Q3 2021.
- Chevy Chase Trust's portfolio value fell 2.4% quarter-over-quarter to $28.7B.
Based on Chevy Chase Trust's 13F filing for Q3 2021, filed 20 Oct 2021.